Core Scientific, Inc. (CORZR)
OTCMKTS · Delayed Price · Currency is USD
0.0350
-0.0050 (-12.50%)
At close: Feb 6, 2026
Core Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 67.24 | 101.93 | 112.07 | 242.52 | 327.56 | 54.19 |
Other Revenue | 266.94 | 408.74 | 390.33 | 397.8 | 216.93 | 6.13 |
| 334.18 | 510.67 | 502.4 | 640.31 | 544.48 | 60.32 | |
Revenue Growth (YoY) | -40.08% | 1.65% | -21.54% | 17.60% | 802.66% | 1.34% |
Cost of Revenue | 300.05 | 377.37 | 378.94 | 631.91 | 305.62 | 50.93 |
Gross Profit | 34.14 | 133.3 | 123.46 | 8.4 | 238.86 | 9.39 |
Selling, General & Admin | 204.89 | 132.65 | 100.93 | 223.71 | 64.55 | 16.33 |
Research & Development | 11.83 | 11.83 | 7.18 | 26.96 | 7.67 | 5.27 |
Other Operating Expenses | -26.5 | 3.81 | 4.43 | 187.02 | 32.39 | -0.07 |
Operating Expenses | 190.22 | 148.29 | 112.54 | 437.69 | 104.61 | 21.53 |
Operating Income | -156.08 | -14.99 | 10.92 | -429.29 | 134.25 | -12.14 |
Interest Expense | -15.4 | -37.07 | -86.24 | -96.83 | -44.35 | -4.44 |
Currency Exchange Gain (Loss) | -4.21 | -4.21 | -1.96 | -28.03 | -0.12 | -0 |
Other Non Operating Income (Expenses) | -586.85 | -1,369 | 2.53 | 42.2 | -0 | -0.11 |
EBT Excluding Unusual Items | -744.08 | -1,425 | -74.75 | -511.94 | 89.77 | -16.69 |
Merger & Restructuring Charges | -5.51 | - | - | -6.8 | - | - |
Impairment of Goodwill | - | - | - | -1,055 | - | - |
Asset Writedown | - | - | - | -590.74 | - | - |
Legal Settlements | -13.43 | - | - | - | -2.64 | 5.81 |
Other Unusual Items | -1.38 | 110.95 | -171.06 | 0.77 | -24.06 | -1.33 |
Pretax Income | -767.44 | -1,314 | -245.8 | -2,163 | 63.08 | -12.21 |
Income Tax Expense | 0.86 | 0.86 | 0.68 | -17.09 | 15.76 | - |
Net Income | -768.31 | -1,315 | -246.49 | -2,146 | 47.31 | -12.21 |
Preferred Dividends & Other Adjustments | -114.06 | -192.59 | - | - | - | 10.48 |
Net Income to Common | -654.25 | -1,122 | -246.49 | -2,146 | 47.31 | -22.68 |
Shares Outstanding (Basic) | 304 | 256 | 380 | 341 | 207 | 158 |
Shares Outstanding (Diluted) | 304 | 256 | 380 | 341 | 233 | 158 |
Shares Change (YoY) | 6.29% | -32.65% | 11.51% | 46.01% | 48.03% | 59.70% |
EPS (Basic) | -2.15 | -4.39 | -0.65 | -6.30 | 0.23 | -0.14 |
EPS (Diluted) | -2.15 | -4.39 | -0.65 | -6.30 | 0.20 | -0.14 |
Free Cash Flow | -343.97 | -52.07 | 48.95 | -396.47 | -56.74 | -25.33 |
Free Cash Flow Per Share | -1.13 | -0.20 | 0.13 | -1.16 | -0.24 | -0.16 |
Gross Margin | 10.21% | 26.10% | 24.57% | 1.31% | 43.87% | 15.57% |
Operating Margin | -46.71% | -2.94% | 2.17% | -67.04% | 24.66% | -20.12% |
Profit Margin | -195.78% | -219.79% | -49.06% | -335.20% | 8.69% | -37.61% |
Free Cash Flow Margin | -102.93% | -10.20% | 9.74% | -61.92% | -10.42% | -42.00% |
EBITDA | -75.23 | 98.22 | 106.92 | -204.03 | 167.61 | -2.74 |
EBITDA Margin | -22.51% | 19.23% | 21.28% | -31.86% | 30.78% | -4.54% |
D&A For EBITDA | 80.86 | 113.21 | 96 | 225.26 | 33.36 | 9.4 |
EBIT | -156.08 | -14.99 | 10.92 | -429.29 | 134.25 | -12.14 |
EBIT Margin | -46.71% | -2.93% | 2.17% | -67.04% | 24.66% | -20.12% |
Effective Tax Rate | - | - | - | - | 24.99% | - |
Revenue as Reported | 334.18 | 510.67 | 502.4 | 640.31 | 544.48 | 60.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.